抗体增强哺乳动物气味受体的细胞表面表达
Ikumi Takayama1, Nako Araki1, Jeevan Tewari2
1Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Koganei 184-8588, Tokyo, Japan.
International journal of molecular sciences
|February 26, 2025
概括
小分子抗剂通过作为药理伴侣来增强细胞中的气味受体 (OR) 表达. 这稳定了ORs,改善了它们的表面表达和功能,为嗅觉机制提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 脊椎动物嗅觉受体 (ORs) 的功能性表征,是一种G蛋白合受体 (GPCR),对于理解嗅觉至关重要.
- 由于非嗅觉细胞的结构不稳定性,ORs的异质表达通常具有挑战性.
- 抗剂以前通过增加结构稳定性,在一些非嗅觉GPCR突变体中恢复了膜表达.
研究的目的:
- 调查小分子抗剂是否可以增强异质细胞中ORs的膜表达.
- 探索对抗剂作为ORs的药理伴侣的潜力.
主要方法:
- 利用甲酸盐 (PES) 作为小鼠OR或Or11g7表达在异质细胞中的对抗剂.
- 评估细胞表面表达水平,比较抗体效应与OR伴侣RTP1S的共同表达.
- 测试了对抗剂去除后Or11g7的激动剂反应.
- 研究了对抗剂对人类OROR2T11.11的影响.
主要成果:
- 甲酸盐显著增加了小鼠Or11g7的细胞表面表达,超过了RTP1S的影响.
- 在移除对抗剂后,Or11g7保持了正常的激动剂反应.
- 对人类OR2T11进行了类似的细胞表面表达增强,当与其抗剂进行治疗时.
结论:
- 小分子气味对抗剂作为药理伴侣,稳定OR形状并增强表面表达.
- 这一发现揭示了OR生物发生过程中对抗剂的新型作用,类似于分子伴侣.
- 结果可能会为未来关于嗅觉训练机制和OR功能研究的研究提供信息.
相关概念视频
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
Drug-Receptor Interaction: Antagonist
2.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.6K
Opioid Receptors: Overview
426
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
426
Drug-Receptor Interactions
4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K
The Physiology of Taste
3.7K
The perception of a salty flavor is facilitated by sodium ions within the oral salivary fluid. Upon consumption of a salty substance, salt crystals disassemble, leading to the liberation of its constituents—Na+ and Cl- ions. These ions subsequently dissolve into the salivary fluid present in the oral cavity. The external environment of the gustatory cells experiences an elevation in Na+ concentration, thereby establishing a potent concentration gradient. This gradient propels the...
3.7K
G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K


